ATE312812T1 - Vanilloid-analoge die resiniferatoxin- pharmacophore enthalten als wirksame vanilloid rezeptor agonisten und analgetika, zusammensetzungen und ihre verwendung - Google Patents

Vanilloid-analoge die resiniferatoxin- pharmacophore enthalten als wirksame vanilloid rezeptor agonisten und analgetika, zusammensetzungen und ihre verwendung

Info

Publication number
ATE312812T1
ATE312812T1 AT00905438T AT00905438T ATE312812T1 AT E312812 T1 ATE312812 T1 AT E312812T1 AT 00905438 T AT00905438 T AT 00905438T AT 00905438 T AT00905438 T AT 00905438T AT E312812 T1 ATE312812 T1 AT E312812T1
Authority
AT
Austria
Prior art keywords
vanilloid
analogues
receptor agonists
analgesics
compositions
Prior art date
Application number
AT00905438T
Other languages
English (en)
Inventor
Jeewoo Lee
Uhtaek Oh
Young-Ger Suh
Hyeung-Geun Park
Hee-Doo Kim
Original Assignee
Pacific Corp
Digital Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pacific Corp, Digital Biotech Co Ltd filed Critical Pacific Corp
Application granted granted Critical
Publication of ATE312812T1 publication Critical patent/ATE312812T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
    • C07C335/10—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C335/12—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00905438T 1999-02-22 2000-02-21 Vanilloid-analoge die resiniferatoxin- pharmacophore enthalten als wirksame vanilloid rezeptor agonisten und analgetika, zusammensetzungen und ihre verwendung ATE312812T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19990005751 1999-02-22
PCT/KR2000/000137 WO2000050387A1 (en) 1999-02-22 2000-02-21 Vanilloid analogues containing resiniferatoxin pharmacophores as potent vanilloid receptor agonists and analgesics, compositions and uses thereof

Publications (1)

Publication Number Publication Date
ATE312812T1 true ATE312812T1 (de) 2005-12-15

Family

ID=36578904

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00905438T ATE312812T1 (de) 1999-02-22 2000-02-21 Vanilloid-analoge die resiniferatoxin- pharmacophore enthalten als wirksame vanilloid rezeptor agonisten und analgetika, zusammensetzungen und ihre verwendung

Country Status (12)

Country Link
US (1) US6476076B1 (de)
EP (1) EP1154989B1 (de)
JP (1) JP3727851B2 (de)
CN (1) CN1210254C (de)
AT (1) ATE312812T1 (de)
AU (1) AU763824B2 (de)
CA (1) CA2363531C (de)
DE (1) DE60024785T2 (de)
ES (1) ES2253208T3 (de)
HK (1) HK1042472B (de)
MX (1) MXPA01008403A (de)
WO (1) WO2000050387A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100348819B1 (ko) * 1999-02-22 2002-08-17 주식회사 태평양 레시니페라톡신 약리기를 함유하여 강력한 바닐로이드수용체의 효현제 및 진통제로서 사용하는 바닐로이드동족체 및 이를 함유하는 약학적 조성물
JP3501775B2 (ja) * 2000-05-31 2004-03-02 ファイザー株式会社 ヒトバニロイド受容体様タンパク質
KR20030024799A (ko) * 2000-07-20 2003-03-26 뉴로젠 코포레이션 캡사이신 수용체 리간드
MXPA03001535A (es) 2000-08-21 2004-12-13 Pacific Corp Derivados de tiourea novedosos y las composiciones farmaceuticas que contienen los mismos.
DE60120421T2 (de) * 2000-08-21 2006-12-28 Pacific Corp. Neue (thio)harnstoffverbindungen und arzneimittelkompositionen, die diese enthalten
WO2002076444A1 (en) * 2001-03-22 2002-10-03 The Government Of The United States, As Represented By The Secretary Of The Department Of Health And Human Services Molecular neurochirurgerie for pain control administering locally capsaicin or resiniferatoxin
US20040146590A1 (en) 2001-03-22 2004-07-29 Iadarola Michael J Molecular neurochirurgie for pain control administering locally capsaicin or resinferatoxin
AU2002325381A1 (en) * 2001-07-31 2003-02-24 Bayer Healthcare Ag Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
PE20030417A1 (es) 2001-09-13 2003-08-06 Smithkline Beecham Plc Derivados de urea como antagonistas del receptor vainilloide
US6872748B2 (en) * 2001-09-27 2005-03-29 Digital Biotech Co., Ltd. Simplified resiniferatoxin analogues as vanilloid receptor agonist showing excellent analgesic activity and the pharmaceutical compositions containing the same
US20040259912A1 (en) * 2001-09-28 2004-12-23 Takahiro Matsumoto Benzine derivatives, process for preparing the same and use thereof
WO2003055848A2 (en) * 2001-12-26 2003-07-10 Bayer Healthcare Ag Urea derivatives as vr1- antagonists
RS63204A (en) * 2002-01-17 2006-10-27 Neurogen Corporation Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
US7074805B2 (en) 2002-02-20 2006-07-11 Abbott Laboratories Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
ES2319886T3 (es) * 2002-02-20 2009-05-14 Abbott Laboratories Compuestos azabiciclicos condensados que inhiben el sutipo 1 del receptor valinoide (vr1).
BR0309940A (pt) * 2002-05-08 2005-02-09 Bayer Healthcare Ag Derivados de hidróxi-tetraidro-naftaleniluréia
DE10224107A1 (de) * 2002-05-29 2003-12-11 Gruenenthal Gmbh Kombination ausgewählter Opioide mit anderen Wirkstoffen zur Therapie der Harninkontinenz
US7381840B2 (en) 2002-12-06 2008-06-03 Xention Limited Tetrahydro-naphthalene derivatives
DK1572632T3 (da) 2002-12-09 2008-10-27 Xention Ltd Tetrahydro-naphthalenderivater som vanilloidreceptorantagonister
EP1438942A1 (de) * 2003-01-17 2004-07-21 Schering Oy Medikamentenabgabevorrichtung für das Mittelohr und Nase
US6933311B2 (en) 2003-02-11 2005-08-23 Abbott Laboratories Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
ES2293217T3 (es) 2003-02-12 2008-03-16 Bayer Healthcare Ag Derivados de hidroxi-tetrahidro-naftalenilurea.
US20040202735A1 (en) * 2003-04-08 2004-10-14 Moore Bob M. Method and kit for controlling bleeding
EP2907503A1 (de) 2003-04-10 2015-08-19 Neurogesx, Inc. Verfahren und Zusammensetzungen zur Verabreichung von TRPV1-Agonisten
KR100707123B1 (ko) * 2003-07-02 2007-04-16 그뤼넨탈 게엠베하 바닐로이드 수용체의 길항제로서 강력한 진통효과를나타내는 4-(메틸설포닐아미노)페닐 동족체 및 이를함유하는 약학적 조성물
EP1670761B1 (de) 2003-10-01 2009-01-28 Xention Limited Tetrahydronaphthalin- und harnstoffderivate
WO2005035471A1 (ja) 2003-10-14 2005-04-21 Ajinomoto Co., Inc. エーテル誘導体
WO2005044802A2 (en) 2003-11-08 2005-05-19 Bayer Healthcare Ag Tetrahydro-quinolinylurea derivatives as vrl antagonists
ES2315716T3 (es) * 2003-11-08 2009-04-01 Bayer Healthcare Ag Derivados de amida, carbamato o urea biciclica como moduladores del receptor vanilloide.
US20060047171A1 (en) * 2003-12-22 2006-03-02 Harold Meckler Catalytic hydrogenation of nitriles to produce capsaicinoid derivatives and amine compounds, and methods for purifying and obtaining the polymorphs thereof
GB0412769D0 (en) * 2004-06-08 2004-07-07 Novartis Ag Organic compounds
WO2006098554A1 (en) * 2005-03-16 2006-09-21 Amorepacific Corporation Novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and a pharmaceutical composition containing the same
EA200702020A1 (ru) * 2005-03-19 2008-02-28 Эморпасифик Корпорейшн Новые соединения, их изомеры или фармацевтически приемлемые соли в качестве антагонистов ваниллоидных рецепторов и содержащие их фармацевтические композиции
ATE464571T1 (de) * 2005-11-04 2010-04-15 Nxp Bv Verfahren und testvorrichtung zur prüfung integrierter schaltungen
JP2010501592A (ja) 2006-08-25 2010-01-21 アボット・ラボラトリーズ Ｔｒｐｖ１を阻害するインダゾール誘導体およびその使用
EP2134678A2 (de) 2006-12-20 2009-12-23 Abbott Laboratories N-(5,6,7,8-tetrahydronaphthalin-1-yl)harnstoffderivate und verwandte verbindungen als antagonisten des trpv1-vanilloidrezeptors zur behandlung von schmerzen
EP2489660A1 (de) 2008-03-20 2012-08-22 Abbott Laboratories Verfahren zum Herstellen von Mitteln für das zentrale Nervensystem, die TRPV1-Antagonisten sind
WO2010119877A1 (ja) * 2009-04-13 2010-10-21 味の素株式会社 アミジン誘導体の製造方法
NO2629610T3 (de) 2010-07-27 2018-02-03
CA2819635A1 (en) 2010-12-01 2012-06-07 Spinal Modulation, Inc. Directed delivery of agents to neural anatomy
US9956166B2 (en) 2013-09-18 2018-05-01 Sorrento Therapeutics, Inc. Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
WO2018136943A1 (en) 2017-01-23 2018-07-26 Flex Pharma, Inc. Compositions and methods affecting exercise performance

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021450A (en) * 1989-05-30 1991-06-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof
US5431914A (en) * 1992-04-17 1995-07-11 Adekunle; Michael Method of treating an internal condition by external application of capsaicin without the need for systemic absorption

Also Published As

Publication number Publication date
CA2363531C (en) 2007-07-31
ES2253208T3 (es) 2006-06-01
MXPA01008403A (es) 2003-06-06
CA2363531A1 (en) 2000-08-31
AU763824B2 (en) 2003-07-31
HK1042472A1 (en) 2002-08-16
DE60024785T2 (de) 2006-09-14
DE60024785D1 (de) 2006-01-19
EP1154989B1 (de) 2005-12-14
JP2002537373A (ja) 2002-11-05
JP3727851B2 (ja) 2005-12-21
EP1154989A1 (de) 2001-11-21
CN1210254C (zh) 2005-07-13
WO2000050387A1 (en) 2000-08-31
US6476076B1 (en) 2002-11-05
HK1042472B (zh) 2005-12-09
CN1342138A (zh) 2002-03-27
AU2697600A (en) 2000-09-14

Similar Documents

Publication Publication Date Title
ATE312812T1 (de) Vanilloid-analoge die resiniferatoxin- pharmacophore enthalten als wirksame vanilloid rezeptor agonisten und analgetika, zusammensetzungen und ihre verwendung
DE602005020655D1 (de) Carboxamid-spirolactam-cgrp-rezeptor-antagonisten
EP1606264A4 (de) Monocyclische anilidspirohydantoine als cgrp-rezeptorantagonisten
AR002267A1 (es) Compuestos de imidazol utiles para el tratamiento de patologias mediadas por citoquinas; composicion farmaceutica que los contiene; proceso para preparar dichos compuestos; uso del mismo para preparar dichas composiciones; compuestos intermediarios y procesos para su preparacion.
DE602004013563D1 (de) Rantagonisten
MY137535A (en) New pyrrolidinium derivatives
TW200505903A (en) CGRP receptor antagonists
MX2007013065A (es) Derivados de dihidrobenzofurano y usos de los mismos.
ATE535514T1 (de) Carboxamid-spirohydantoin-cgrp-rezeptor- antagonisten
EP1606286A4 (de) Benzodiazepinspirohydantoine als cgrp-rezeptorantagonisten
DE602004027021D1 (de) Cgrp-rezeptorantagonisten
BRPI0507495A (pt) composto, composição farmacêutica, uso do composto método para o tratamento de distúrbios mediados por mglur5, e, método para inibir a ativação de receptores de mglur5
ATE516803T1 (de) Aryl-spirohydantoin-cgrp-rezeptor-antagonisten
EP1861399A4 (de) Cgrp-rezeptorantagonisten
HRP941000B9 (hr) Morfolin i tiomorfolin antagonisti receptora tahikinina
ATE503755T1 (de) Cgrp-rezeptorantagonisten
GT199800042A (es) Nuevos derivados del acido hexanoico.
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
DE60237528D1 (de) Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative
GT200600199A (es) Diarilsulfonas sulfonamidas y su uso
EP1802372A4 (de) Cgrp-rezeptorantagonisten
WO2006041830A3 (en) Cgrp receptor antagonists
CL2003002611A1 (es) Compuestos derivados del acido tiofeno hidroxamico, 2-hidroxamida-5-[(aril o heteroaril)-disutituido-metil]-amida del acido tiofeno-2,5-dicarboxilico enantiomeros, composicion farmaceutica, procedimiento de preparacion, y su uso para el tratamiento d
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
ATE329916T1 (de) Azaindolylpiperidinderivate als antihistaminika und antiallergika

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties